Expected wait times for access to a disease-modifying Alzheimer’s treatment in the United States
This is my archive
Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis
Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer’s disease treatment
Assessing the Preparedness of the Taiwanese Healthcare System Infrastructure for an Alzheimer’s Treatment
